Ronald P. Gladue
Department of Immunology
Pfizer Global Research and Development
Eastern Point Road
Groton
USA
Name/email consistency: high
- The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice. Gladue, R.P., Paradis, T., Cole, S.H., Donovan, C., Nelson, R., Alpert, R., Gardner, J., Natoli, E., Elliott, E., Shepard, R., Bedian, V. Cancer Immunol. Immunother. (2011)
- CCR1 antagonists: what have we learned from clinical trials. Gladue, R.P., Brown, M.F., Zwillich, S.H. Curr. Top. Med. Chem (2010)
- The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. Gladue, R.P., Cole, S.H., Roach, M.L., Tylaska, L.A., Nelson, R.T., Shepard, R.M., McNeish, J.D., Ogborne, K.T., Neote, K.S. J. Immunol. (2006)